SOMETECH Proves Its Presence at MEDICA 2024… Focused on Expanding Sales
- 작성일2025/02/13 09:25
- 조회 311
Leading Manufacturer of 3D Laparoscopes and Surgical Microscopes, SOMETECH (CEO Yang Hee-bong), announced its participation in the world’s largest medical device exhibition, MEDICA 2024, held in Düsseldorf, Germany.
The MEDICA exhibition in Germany is one of the largest medical device trade shows globally, covering key areas such as diagnostic medicine, digital healthcare, medical imaging devices, laboratory technology, mobile healthcare, physiotherapy/orthopedic technology, and medical consumables. This year, around 5,000 companies from around the world showcased their new products and technologies at this prestigious event.
After resuming participation in MEDICA since the pandemic, SOMETECH continued to make its mark, following last year’s success. The company participated in the event from November 11th to 14th, with a booth showcasing its products. Leading the presentation was its 4K 3D surgical microscope, the VOMS-400, alongside its 3D laparoscopes (VLS-200, COT-200), 4K endoscope system (VES-400), and the company’s existing best-sellers, the ST-501 and DCS-pro.
Notably, the 4K 3D surgical microscope is a cutting-edge product developed based on advanced optical technology, offering sharp image quality and depth perception. Additionally, through a joint booth with the Ministry of Health and Welfare and Seoul National University Bundang Hospital, Professor Woo Se-jun from Seoul National University Bundang Hospital presented on the VOMS-400 OPH, attracting significant attention on the 12th.
A company representative stated, “We have left a strong impression on existing buyers, and new customers were also captivated, resulting in noticeable demand.” He emphasized that SOMETECH plans to focus on expanding product sales throughout the Middle East, Africa, Russia, Latin America, and across Asia, where demand is consistently growing.
Furthermore, SOMETECH is also set to participate in ARAB HEALTH, scheduled for the end of January next year, where the company will continue to focus on promoting its products globally and highlighting the strengths of its various product lines.
Source: Medical News
Translated from Korean.
Original available here: